Swiss Lions 100 | 2026 edition
Ypsomed
Ypsomed is No. 76 in the Swiss Lions 100 and No. 10 in Life Sciences & Health, with a score of 41.2 out of 100. Headquarters: Burgdorf, canton of Bern.
- Swiss Lions score
- 41.2
- Overall rank
- 76of 100
- Life Sciences & Health
- 10of 14
About
Medical technology company in Burgdorf, canton of Bern, making injection pens and autoinjectors.
How the score is made
Global scale
CHF 731m revenue.
Swiss value
Swiss made: Partly.
Prominence
Online attention across languages, and worldwide search interest.
Impact
Net-zero target validated. Not a certified B Corp.
Philanthropy
Corporate foundation: Ypsomed Innovationsfonds.
Key figures
- Revenue used in the ranking
- CHF 731mTTM Oct 2026, company
- Revenue
- CHF 731mTwelve months to 31 March 2026
- Net profit
- CHF 222mAttributable to shareholders
- Dividends paid
- CHF 30mTo all shareholders
- Employees worldwide
- 2,025
Employees in Switzerland and dividends paid to Swiss shareholders are not published consistently, so they are not shown.
Profile
- Headquarters
- BurgdorfCanton of Bern
- Language region
- German-speaking
- Category
- Life Sciences & Health
- Ownership
- Listed
- Main customers
- Consumers and businesses
- Chief executive
- Simon MichelSince 2014. Source
- Formed
- 2003Spin-off from Disetronic
Nearby in the Swiss Lions 100
Also in Life Sciences & Health
1RocheScore 80.8
2NovartisScore 78.6
3LonzaScore 59.5
4SonovaScore 54.8
5SandozScore 54.5
6StraumannScore 53.5
See all 14 brands in Life Sciences & Health.
Sources
- Revenue used in the ranking: stockanalysis.com YPSN (TTM Oct 2026).
- Revenue, net profit, dividends and employees: stockanalysis.com, from company filings.
- Climate target: Science Based Targets initiative dashboard, October 2026. Foundations: Swiss commercial register. B Corp: B Lab directory.
Something out of date?
If a figure is wrong, or Ypsomed can publish figures for the next edition, tell us. Corrections are recorded with their source.